BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $136,957,000 | +49.0% | 1,710,895 | +0.3% | 0.17% | +29.8% |
| Q4 2018 | $91,927,000 | -29.4% | 1,705,175 | +2.2% | 0.13% | -13.2% |
| Q3 2018 | $130,265,000 | +22.3% | 1,668,781 | -0.5% | 0.15% | +18.9% |
| Q2 2018 | $106,503,000 | -28.0% | 1,677,731 | +4.0% | 0.13% | -31.4% |
| Q1 2018 | $147,970,000 | +20.2% | 1,613,636 | -1.1% | 0.18% | +24.2% |
| Q4 2017 | $123,070,000 | +17.4% | 1,632,006 | +8.4% | 0.15% | +15.5% |
| Q3 2017 | $104,871,000 | +35.7% | 1,505,254 | -1.3% | 0.13% | +35.8% |
| Q2 2017 | $77,272,000 | +199.4% | 1,525,002 | +136.3% | 0.10% | +206.5% |
| Q1 2017 | $25,810,000 | – | 645,397 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |